Jill Leversage insider trades
Open-market stock purchases and sales by Jill Leversage, Director at Aurinia Pharmaceuticals Inc, from SEC Form 4 filings since Jan 29, 2021.
Track record: 50% of 2 scored buys are up 5% or more since purchase, averaging +7%.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- AUPH Aurinia Pharmaceuticals Inc: 4 buys, 2 sales, last Nov 21, 2024